Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 852, Issue 1-2, 2007, Pages 519-528

  Unceta, Nora ^a   Barrondo, Sergio ^a   de Azúa, Iñigo Ruiz ^a   Gómez Caballero, Alberto ^a   Goicolea, M Aranzazu ^a   Sallés, Joan ^a   Barrio, Ramón J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Chiral derivatization; Chronic treatment with fluoxetine; Fluoxetine and norfluoxetine enantiomers; HPLC FD; Rat plasma and brain levels

Indexed keywords

BRAIN LEVELS; CHIRAL DERIVATIZATION; FLUOXETINE; NORFLUOXETINE ENANTIOMERS; RAT PLASMA;

BODY FLUIDS; BRAIN; CONCENTRATION (PROCESS); FLUORESCENCE; RATS; TISSUE;

ENANTIOMERS;

1 (NAPHTHYL)ETHYL ISOCYANIC ACID; FLUOXETINE; ISOCYANIC ACID DERIVATIVE; NORFLUOXETINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHIRALITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ENANTIOMER; ENANTIOSELECTIVITY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUOXETINE; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

RATTUS;

EID: 34249736430     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.02.008     Document Type: Article

References (40)

1. Amsterdam J.D. Am. J. Psychiatry 154 (1997) 963
2. Fava M.M. J. Clin. Psychiatry 56 (1995) 52
3. Perez V., Puigdemont D., Gilaberte I., Alvarez E., and Artigas F. J. Clin. Psychopharmacol. 21 (2001) 36
4. Fuller R.W., Snoddy H.D., Krushinsky J.H., and Robertson D.W. Neuropharmacology 31 10 (1992) 997
5. Wong D.T., Fuller R.W., and Robertson D.W. Acta Pharm. Nord. 2 3 (1990) 171
6. Margolis J.M., O'Donnell J.P., and Mankowski D.C. Drug Metab. Dispos. 28 (2000) 1187
7. Ring B.J., Eckstein J.A., and Gillespie J.S. J. Pharmacol. Exp. Ther. 297 (2001) 1044
8. Eap C.B., Bondolfi G., and Zullino D. J. Clin. Psychopharmacol. 21 (2001) 330
9. Van Moltke L.L., Greenblatt D., and Duan S.X. Psychopharmacology 132 (1997) 402
10. Invernizzi R., Bramante M., and Samanin R. Eur. J. Pharmacol. 260 (1994) 243
11. Le Poul E., Laaris N., Doucet E., Laporte A.M., Hamon M., and Lanfumey L. Arch. Pharm. 352 (1995) 141
12. Welner S.A., de Montigny C., Desroches J., Desjardins P., and Suranyi-Cadotte B.E. Synapse 4 (1989) 347
13. Hensler J.G., Covachich A., and Frazer A. Neuropsychopharmacology 4 (1991) 131
14. Hervás I., Vilaró M.T., Romero L., Scorza C., Mengod G., and Artigas F. Neuropsychopharmacology 24 (2001) 11
15. Nash J.F., Bopp R.J., Carmichael R.H., Farid K.Z., and Lembreger L. Clin. Chem. 28 (1982) 2100
16. Crifasi J.A., Le N.X., and Long C. J. Anal. Toxic. 21 6 (1997) 415
17. Fontanille P., Jourdil N., Villier C., and Bessard G. J. Chromatogr. Biomed. Sci. Appl. 692 2 (1997) 337
18. Alvarez J.C., Bothua D., Collingnon I., Advernier C., and Spreux-Varoquaux O. J. Chromatogr. Biomed. Sci. Appl. 707 1-2 (1998) 175
19. Gupta R.N., and Steiner M. J. Liquid Chromatogr. 13 19 (1990) 3785
20. Guo X., Fukushima T., Li F., and Imai K. Biomed. Chromatogr. 17 1 (2003) 1
21. Green R., Houghton R., Scarth J., and Gregory C. Chromatographia 55 (2002) 133
22. Olsen B.A., Wirth D.D., and Larew J.S. J. Pharm. Biomed. Anal. 17 (1998) 623
23. Gatti G., Bonimi I., Marchiselli R., Fattore C., Spina E., Scordo G., Pacifici R., and Perucca E. J. Chromatogr. B 784 (2003) 375
24. Eap C.B., Gaillard N., Powell K., and Baumann P. J. Chromatogr. B 682 (1996) 265
25. Torok-Both G.A., Baker G.B., Coutts R.T., Mckenna K.F., and Aspeslet L.J. J. Chromatogr. 579 (1992) 99
26. Potts B.D., and Parli C.J. J. Liquid Chromatogr. 15 (1992) 665
27. Nichols J.H., Charlson J.R., and Lawson G.M. Clin. Chem. 40 (1994) 1312
28. Kristoffersen L., Bugge A., Lundanes E., and Slordal L. J. Chromatogr. B Biomed. Sci. Appl. 734 2 (1999) 229
29. Unceta N., Barrondo S., Rodriguez E., Sampedro C., Goicolea M.A., Sallés J., and Barrio R.J. Anal. Chim. Acta 444 (2001) 211
30. Caccia S., Fracasso C., Garattini S., Guiso G., and Sarati S. Neuropharmacology 31 (1992) 343
31. Muck-Seler D., Jevric-Causevic A., and Diksic M. J. Neurochem. 67 (1996) 2434
32. Durand M., Berton O., Aguerre S., Edno L., Combourien I., Mormede P., and Chaouloff F. Neuropharmacology 38 (1999) 893
33. Castro M.E., Diaz A., del Olmo E., and Pazos A. Neuropharmacology 44 (2003) 93
34. Caccia S., Cappi M., Fracasso C., and Garattini S. Psychopharmacology 100 (1990) 509
35. Benfield P., Hell R.C., and Lewis S.P. Drugs 32 (1986) 481
36. Kelly M.W., Perry P.J., Holstad S.G., and Garvey M.J. Ther. Drug Monitor. 11 (1989) 163
37. Keck P.E., and McElroy S.L. J. Clin. Psychiatry 53 (1992) 127
38. Brunswick D.J., Amsterdam J.D., Fawcett J., Quitkin F.M., Reimberr F.W., Rosenbaum J.F., and Beasley Jr. C.M. J. Affec. Disord. 68 (2002) 243
39. Altamura A.C., Moro A.R., and Percudani M. Clin. Pharmacokinet. 26 (1994) 201
40. Li K.M., Thompson M.R., and McGregor I.S. J. Chromatogr. B 804 (2004) 319